Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 13

Rhinophyma: Prevalence, Severity, Impact and Management

Authors Chauhan R, Loewenstein SN, Hassanein AH

Received 26 January 2020

Accepted for publication 21 July 2020

Published 11 August 2020 Volume 2020:13 Pages 537—551

DOI https://doi.org/10.2147/CCID.S201290

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Jeffrey Weinberg


Ruvi Chauhan, Scott N Loewenstein, Aladdin H Hassanein

Indiana University School of Medicine, Department of Surgery, Division of Plastic Surgery, Indianapolis, IN, USA

Correspondence: Aladdin H Hassanein
Indiana University School of Medicine, Department of Surgery, Division of Plastic Surgery, 545 Barnhill Drive, Suite 232, Indianapolis, IN 46202, USA
Tel +1 317-944-3636
Fax +1 317-968-0733
Email ahassane@iu.edu

Abstract: Rhinophyma is an advanced stage of rosacea affecting the nasal soft tissues and resulting in disruption of the nasal architecture, airway obstruction, and disfigurement of the nasal aesthetic units. Rhinophyma presents with hypertrophy of the nasal soft tissues, erythema, telangiectasias, nodules, and lobules with a bulbous appearance. Significant psychosocial morbidity is associated with the disease. Understanding of this disease has improved and multiple treatment options exist. The article is a review of the literature to evaluate the pathophysiology, clinical presentation, and epidemiology of keywords “rhinophyma” and “rosacea” using an OVID Medline and PubMed search along with a systematic review of outcomes pertaining to treatment of rhinophyma with laser therapy, scalpel excision, and the subunit method using an OVID Medline search. The subunit method has the highest complication and revision rates followed by carbon dioxide laser therapy. Outcomes between carbon dioxide laser and scalpel therapy and electrocautery are equivalent. Scalpel excision is a more cost-effective treatment modality with less post-operative complications; however, it risks poor hemostasis intraoperatively. Patient satisfaction is common post-therapy regardless of the treatment method. Over 89% of patients would recommend undergoing treatment for rhinophyma irrespective of treatment type. Treatment options vary, and choice of treatment can be dependent on practitioner and patients’ treatment goals.

Keywords: subunit method, phyma, systematic review

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]